ISSN:

Journal Home

Alzheimer's Research and Therapy Q1 Unclaimed

BioMed Central Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Alzheimer's Research and Therapy is a journal indexed in SJR in Neurology (clinical) and Cognitive Neuroscience with an H index of 88. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1529 €. The scope of the journal is focused on Alzheimer's disease, dementia, neurodegenerative diseases. It has an SJR impact factor of 2,65 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,65.

Alzheimer's Research and Therapy focuses its scope in these topics and keywords: alzheimer’s, disease, patients, memory, amyloid, impairment, diseaselongitudinal, learning, interventionsreactions, implications, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cognitive Neuroscience (Q1) Neurology (Q1) Neurology (clinical) (Q1) Neurology (clinical) (Q1)

Price

1529 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

2,65

SJR Impact factor

88

H Index

197

Total Docs (Last Year)

471

Total Docs (3 years)

10300

Total Refs

4100

Total Cites (3 years)

467

Citable Docs (3 years)

8.18

Cites/Doc (2 years)

52.28

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Neurology Q1
JAMA Neurology Q1
Nature Reviews Neurology Q1
Molecular Neurodegeneration Q1
Acta Neuropathologica Q1

Compare this journals